To further explore the significance of our in vitro and in vivo findings in a clinical context, we evaluated the transcriptional expression of Cx43 in human breast carcinoma tissues of different subtypes, according to the expression of ER, PR and HER2, markers that predict the prognosis of breast cancer and guide the patients selection for therapy. Here, GJA1 is linked to breast carcinoma.